Jinthe Van Loenhout
Wilrijk, VLG 2610, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers.
Journal: Antioxidants (Basel, Switzerland)
Published: February 02, 2023
Co-Targeting the EGFR and PI3K/Akt Pathway to Overcome Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma: What about Autophagy?
Journal: Cancers
Published: October 24, 2022
Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model.
Journal: Pharmaceutics
Published: October 24, 2022
Auranofin and Cold Atmospheric Plasma Synergize to Trigger Distinct Cell Death Mechanisms and Immunogenic Responses in Glioblastoma.
Journal: Cells
Published: September 16, 2021
Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer.
Journal: Redox biology
Published: December 10, 2020
Oxidative Stress-Inducing Anticancer Therapies: Taking a Closer Look at Their Immunomodulating Effects.
Journal: Antioxidants (Basel, Switzerland)
Published: October 29, 2020
Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment.
Journal: Clinical & translational immunology
Published: May 17, 2020
Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells.
Journal: Cancers
Published: August 13, 2019
Non-Thermal Plasma as a Unique Delivery System of Short-Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 14, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026